Shawn Egan

Stock Analyst at Citigroup

(2.06)
# 2,814
Out of 4,711 analysts
4
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
Nov 27, 2024
Maintains: Neutral
Price Target: $27$26
Current: $19.45
Upside: +33.68%